WithdrawnNot Applicable

PhysioTouch for Treatment of Radiation Fibrosis

Stopped: Reduction in available resources

0Started 2018-12

Plain-language summary

A quarter of a million women will develop breast cancer (BC) in this year alone. Many of these women will have side effects as a result of their breast cancer treatment. Radiation Fibrosis Syndrome (RFS) is a common complication from breast cancer treatment that progressively changes tissue and can cause decreased function, pain, and range of motion. The PhysioTouch is a hand held device that can be used to treat RFS and may improve the treatment of fibrotic tissue. This pilot randomized controlled trial aims to determine the efficacy of using the PhysioTouch in addition to current standard of care for treatment of BC-related RFS.

Who can participate

Age range21 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * History of radiation therapy for breast cancer * Clinical or suspected RFS * Reported functional impairments Exclusion Criteria: * Metastatic disease of soft tissue * History of bilateral radiation therapy * Previously diagnosed shoulder impairments not related to RFS * Prior treatment with PhysioTouch * Current or recent pregnancy * Current breastfeeding * Other contraindications to safe and meaningful participation at discretion of study team

What they're measuring

Change in self-reported upper extremity function

Timeframe: Baseline to 12 weeks

Change in self-reported pain

Timeframe: Baseline to 12 weeks

Trial details

NCT IDNCT03496909

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-04

View on ClinicalTrials.gov More Radiation Fibrosis trials